93 related articles for article (PubMed ID: 8090331)
21. Serum pyridinoline as a specific marker of collagen breakdown and bone metabolism in hemodialysis patients.
Ureña P; Ferreira A; Kung VT; Morieux C; Simon P; Ang KS; Souberbielle JC; Segre GV; Drüeke TB; De Vernejoul MC
J Bone Miner Res; 1995 Jun; 10(6):932-9. PubMed ID: 7572317
[TBL] [Abstract][Full Text] [Related]
22. Biochemical parameters of bone turnover in kidney transplant recipients.
Smalcelj R; Kusec V; Puretić Z; Mareković Z
Wien Klin Wochenschr; 1998 May; 110(9):326-30. PubMed ID: 9629624
[TBL] [Abstract][Full Text] [Related]
23. Carboxy-terminal propeptide of human type I collagen and pyridinium cross-links as markers of bone growth in infants 1 to 18 months of age.
Lieuw-A-Fa M; Sierra RI; Specker BL
J Bone Miner Res; 1995 Jun; 10(6):849-53. PubMed ID: 7572307
[TBL] [Abstract][Full Text] [Related]
24. Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients.
Małyszko J; Małyszko JS; Pawlak K; Wołczyński S; Myśliwiec M
Adv Med Sci; 2006; 51():69-72. PubMed ID: 17357281
[TBL] [Abstract][Full Text] [Related]
25. Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children.
Baskin E; Beşbaş N; Saatçi U; Hasçelik G; Topaloğlu R; Ozen S; Bakkaloğlu A
Turk J Pediatr; 2004; 46(1):28-31. PubMed ID: 15074371
[TBL] [Abstract][Full Text] [Related]
26. Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry.
Eriksen EF; Charles P; Melsen F; Mosekilde L; Risteli L; Risteli J
J Bone Miner Res; 1993 Feb; 8(2):127-32. PubMed ID: 8442431
[TBL] [Abstract][Full Text] [Related]
27. Increased serum levels of carboxyterminal propeptide of type 1 collagen (PICP) in hyperthyroidism.
Legovini P; De Menis E; Da Rin G; Roiter I; Breda F; Artuso V; Di Virgilio R; Conte N
Horm Metab Res; 1994 Jul; 26(7):334-7. PubMed ID: 7959610
[TBL] [Abstract][Full Text] [Related]
28. Effects of inhaled budesonide on serum markers of bone metabolism in children with asthma.
Sorva R; Turpeinen M; Juntunen-Backman K; Karonen SL; Sorva A
J Allergy Clin Immunol; 1992 Nov; 90(5):808-15. PubMed ID: 1430706
[TBL] [Abstract][Full Text] [Related]
29. Assessment of bone formation by biochemical markers in metabolic bone disease: separation between osteoblastic activity at the cell and tissue level.
Charles P; Hasling C; Risteli L; Risteli J; Mosekilde L; Eriksen EF
Calcif Tissue Int; 1992 Dec; 51(6):406-11. PubMed ID: 1451006
[TBL] [Abstract][Full Text] [Related]
30. Renal osteodystrophy with hyperparathyroidism: the diagnostic value of intact parathormone, alkaline phosphatase, osteocalcin and procollagen.
Rubini G; Anelli F; Correale M; Lauriero F; Rubini D; D'Addabbo A
J Nucl Biol Med (1991); 1994 Sep; 38(3):489-94. PubMed ID: 7865545
[TBL] [Abstract][Full Text] [Related]
31. Serum levels of bone-specific alkaline phosphatase and procollagen type I carboxyterminal peptide in vitamin D deficiency.
Nawawi H; Girgis SI
Southeast Asian J Trop Med Public Health; 2002; 33 Suppl 2():124-30. PubMed ID: 12755282
[TBL] [Abstract][Full Text] [Related]
32. Serum markers of bone metabolism in dogs.
Allen MJ; Hoffmann WE; Richardson DC; Breur GJ
Am J Vet Res; 1998 Mar; 59(3):250-4. PubMed ID: 9522938
[TBL] [Abstract][Full Text] [Related]
33. Serum level of carboxyterminal propeptide of type I procollagen in haemodialysis patients.
Sawamura T; Sasagawa I; Kubota Y; Ishigooka M; Nakada T; Adachi M; Yamaguchi T
Int Urol Nephrol; 1998; 30(1):99-103. PubMed ID: 9569120
[TBL] [Abstract][Full Text] [Related]
34. Assessment of the relationship between dynamic pattern of nighttime levels of melatonin and chosen biochemical markers of bone metabolism in a rat model of postmenopausal osteoporosis.
Ostrowska Z; Kos-Kudla B; Swietochowska E; Marek B; Kajdaniuk D; Górski J
Neuro Endocrinol Lett; 2001 Apr; 22(2):129-36. PubMed ID: 11335889
[TBL] [Abstract][Full Text] [Related]
35. Assessment of biochemical markers of bone metabolism in relation to the occurrence of fracture: a retrospective and prospective population-based study of women.
Akesson K; Ljunghall S; Jonsson B; Sernbo I; Johnell O; Gärdsell P; Obrant KJ
J Bone Miner Res; 1995 Nov; 10(11):1823-9. PubMed ID: 8592961
[TBL] [Abstract][Full Text] [Related]
36. Fluoride and strontium accumulation in bone does not correlate with osteoid tissue in dialysis patients.
Cohen-Solal ME; Augry F; Mauras Y; Morieux C; Allain P; de Vernejoul MC
Nephrol Dial Transplant; 2002 Mar; 17(3):449-54. PubMed ID: 11865091
[TBL] [Abstract][Full Text] [Related]
37. Bone impairment caused by AlCl
Yang X; Yu K; Wang H; Zhang H; Bai C; Song M; Han Y; Shao B; Li Y; Li X
Food Chem Toxicol; 2018 Jun; 116(Pt B):307-314. PubMed ID: 29704576
[TBL] [Abstract][Full Text] [Related]
38. Bone biopsy results and serum bone turnover parameters in uremic children.
Ziólkowska H; Pańiczyk-Tomaszewska M; Debiński A; Polowiec Z; Sawicki A; Sieniawska M
Acta Paediatr; 2000 Jun; 89(6):666-71. PubMed ID: 10914959
[TBL] [Abstract][Full Text] [Related]
39. Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis.
Chen P; Satterwhite JH; Licata AA; Lewiecki EM; Sipos AA; Misurski DM; Wagman RB
J Bone Miner Res; 2005 Jun; 20(6):962-70. PubMed ID: 15883636
[TBL] [Abstract][Full Text] [Related]
40. Serum soluble interleukin-6 receptor and biochemical markers of bone metabolism show significant variations during the menstrual cycle.
Gorai I; Taguchi Y; Chaki O; Kikuchi R; Nakayama M; Yang BC; Yokota S; Minaguchi H
J Clin Endocrinol Metab; 1998 Feb; 83(2):326-32. PubMed ID: 9467535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
